Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Effects of Nanomaterials and Nanoparticles. | J Nanobiotechnology | 2021 | 33407537 | PubTator, text mining | PubMed |
| Mapping germ-layer specification preventing genes in hPSCs via genome-scale CRISPR screening. | iScience | 2021 | 33385119 | PubTator, text mining | PubMed |
| Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression. | Biochim Biophys Acta Rev Cancer | 2021 | 33373647 | PubTator, text mining | PubMed |
| Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists. | Am J Health Syst Pharm | 2021 | 33354706 | PubTator, text mining | PubMed |
| Chiari 1 malformation and exome sequencing in 51 trios: the emerging role of rare missense variants in chromatin-remodeling genes. | Hum Genet | 2021 | 33337535 | PubTator, text mining | PubMed |
| Reliability of neural food cue-reactivity in participants with obesity undergoing bariatric surgery: a 26-week longitudinal fMRI study. | Eur Arch Psychiatry Clin Neurosci | 2021 | 33331960 | PubTator, text mining | PubMed |
| G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer. | Oncogene | 2021 | 33323965 | PubTator, text mining | PubMed |
| ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | Int J Biol Macromol | 2021 | 33301849 | PubTator, text mining | PubMed |
| G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway. | Mol Cancer Res | 2021 | 33298547 | PubTator, text mining | PubMed |
| Type 2 diabetes and remission: practical management guided by pathophysiology. | J Intern Med | 2021 | 33289165 | PubTator, text mining | PubMed |
| Benefits of clinical criteria and high-throughput sequencing for diagnosing children with syndromic craniosynostosis. | Eur J Hum Genet | 2021 | 33288889 | PubTator, text mining | PubMed |
| Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer. | J Biochem Mol Toxicol | 2021 | 33283949 | PubTator, text mining | PubMed |
| Physicians certified by the American Board of Obesity Medicine provide evidence-based care. | Clin Obes | 2021 | 33280270 | PubTator, text mining | PubMed |
| The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells. | Mol Cancer Ther | 2021 | 33277444 | PubTator, text mining | PubMed |
| The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. | Cell Mol Life Sci | 2021 | 33263776 | PubTator, text mining | PubMed |
| Perinatal inflammation alters histone 3 and histone 4 methylation patterns: Effects of MiR-29b supplementation. | Redox Biol | 2021 | 33202301 | PubTator, text mining | PubMed |
| Association of crossing capillaries in the finger nailfold with diabetic retinopathy in type 2 diabetes mellitus. | J Diabetes Investig | 2021 | 33070436 | PubTator, text mining | PubMed |
| Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease. | Clin Res Hepatol Gastroenterol | 2021 | 33036955 | PubTator, text mining | PubMed |
| Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators. | Virology | 2021 | 33032802 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=48